This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWARD J. CANNON, M.D.; ANNA C. NICHOLS, M.S.; IRVING H. LEOPOLD, M.D.

AMA Arch Ophthalmol. 1952;47(3):344-349.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

TERRAMYCIN, an antibiotic with a broad antibacterial spectrum, is an elaboration product of the actinomycete Streptomyces rimosus.¹ Investigators² have reported on the effectiveness of terramycin in the treatment of bacterial, viral, rickettsial, and protozoan diseases. Welch and associates³ have reported on the absorption, distribution, and excretion of this antibiotic after systemic administration to man and the experimental animal. The toxic properties have been investigated by Schoenbach, Bryer, and Long.⁴ The present study was undertaken to evaluate the penetrability of terramycin into the ocular fluids and tissues after local and systemic administration. Additional experiments were devised to study the toxic effects of terramycin on ocular tissues. Since this study was undertaken, reports on the intraocular penetration of terramycin and its clinical effectiveness have appeared.⁵

GENERAL PROCEDURE

Local Administration.

—Solutions: Drops of terramycin hydrochloride in aqueous solution in concentrations of 5 and 25 mg. per cubic centimeter . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA

From the Research Laboratories of the Wills Hospital and the Harrison Department of Surgical Research, University of Pennsylvania School of Medicine.

Footnotes
Presented at a Wills Hospital Conference, March 16, 1951.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?